Serotonin Receptor 2A Gene Polymorphism (–1438A/G) and Short-Term Treatment Response to Citalopram

2005 ◽  
Vol 52 (3) ◽  
pp. 155-162 ◽  
Author(s):  
Myoung-Jin Choi ◽  
Rhee-Hun Kang ◽  
Byung-Joo Ham ◽  
Han-Yong Jeong ◽  
Min-Soo Lee
Keyword(s):  
Gene Polymorphism ◽  
Treatment Response ◽  
Serotonin Receptor ◽  
Term Treatment ◽  
Short Term ◽  
Short Term Treatment ◽  
Serotonin Receptor 2A

scholarly journals Serotonin Transporter Gene Polymorphism Associated with Short-Term Treatment Response to Venlafaxine

2010 ◽  
Vol 62 (3) ◽  
pp. 198-206 ◽  
Author(s):  
Sang-Hyuk Lee ◽  
Tae Kyou Choi ◽  
Eun Lee ◽  
Jeong-Ho Seok ◽  
Sung Hee Lee ◽  
...  
Keyword(s):  
Gene Polymorphism ◽  
Treatment Response ◽  
Serotonin Transporter ◽  
Term Treatment ◽  
Serotonin Transporter Gene ◽  
Transporter Gene ◽  
Short Term ◽  
Short Term Treatment

Fluvoxamine in the Treatment of Trichotillomania: An 8-Week, Open-Label Study

CNS Spectrums ◽  
1998 ◽  
Vol 3 (9) ◽  
pp. 64-71 ◽  
Author(s):  
Gary A. Christenson ◽  
Scott J. Crow ◽  
James E. Mitchell ◽  
Thomas B. Mackenzie ◽  
Ross D. Crosby ◽  
...  
Keyword(s):  
Treatment Response ◽  
Term Treatment ◽  
Hair Pulling ◽  
Short Term ◽  
Open Label ◽  
Short Term Treatment ◽  
Open Label Study ◽  
Label Study ◽  
Long Term Treatment

AbstractThis short-term, open-label study investigates short- and long-term effects of the selective serotonin reuptake inhibitor (SSRI) fluvoxamine for the treatment of trichotillomania (TTM). Additionally, this study aimed to test the hypothesis that the presence of hair pulling compulsiveness is predictive of SSRI response. Nineteen subjects meeting the Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised, (DSM-III-R) criteria for TTM were treated with fluvoxamine at doses up to 300 mg/day. Random regression analysis of change across time for patients who completed the study (n=14) and those who dropped out (n=5) revealed statistically significant improvements in Physician Rating Scale, hair-pulling episodes, Trichotillomania Impairment Scale, and Trichotillomania Symptom Severity Scale, but not in estimated amount of hair pulled. In addition, the percentage of patients' focused or compulsive hair-pulling symptoms was predictive of treatment response. Unfortunately, all three subjects who entered long-term treatment displayed substantial movement back toward baseline by the end of 6 months. We concluded that fluvoxamine produces moderate reductions in symptoms during the short-term treatment of TTM and that the presence of focused or compulsive hair pulling may be predictive of treatment response. However, responses may be short lived when treatment is extended.

scholarly journals F13. PLATELET-LYMPHOCYTE RATIO AS A SHORT-TERM TREATMENT-RESPONSE PREDICTOR IN SCHIZOPHRENIA’S RELAPSE

2019 ◽  
Vol 45 (Supplement_2) ◽  
pp. S258-S259
Author(s):  
Ines Carreira Figueiredo ◽  
Ines Cargaleiro ◽  
Stephanie Mueller ◽  
Pedro Aguiar ◽  
Joana R Batuca ◽  
...  
Keyword(s):  
Treatment Response ◽  
Term Treatment ◽  
Short Term ◽  
Short Term Treatment ◽  
Lymphocyte Ratio ◽  
Platelet Lymphocyte Ratio
Sign in / Sign up

Export Citation Format

Share Document